Chemotherapy versus best supportive care for unresectable non small cell lung cancer: is it really worthwhile?
- 31 March 1993
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 9 (1-6) , 391-395
- https://doi.org/10.1016/0169-5002(93)90696-u
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1991
- Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.Journal of Clinical Oncology, 1990
- A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancerBritish Journal of Cancer, 1990
- Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancerBritish Journal of Cancer, 1989
- Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?Cancer, 1989
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the functional living index—cancerCancer, 1988
- Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1985
- Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinomaCancer, 1982